Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program

PaperCitations, authors & open-access status

Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 140 citations, 2019 year and gold oa status.

140
Citations
2019
Year
gold
OA Status

Related on ScholarIQ

Sebastiano Buti
Author
Renal cell carcinoma treatment
Topic
Renal cell carcinoma treatment
Topic
Cancer Immunotherapy and Biomarkers
Topic
Bladder and Urothelial Cancer Treatments
Topic
470M+ articles · free account